GGrantIndex
← Search

Endothelialized microfluidic assays for emerging therapies in sickle cell disease

$842,828R42FY2023HLNIH

Biochip Labs, Inc., Cleveland OH

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →
Endothelialized microfluidic assays for emerging therapies in sickle cell disease · GrantIndex